Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1460-1465

  Oefelein, Michael G ^a,b   Smith, Norm D ^a   Grayhack, John T ^a   Schaeffer, Anthony J ^a   McVary, Kevin T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WRIGHT PATTERSON AIR FORCE BASE   (United States)

Author keywords

Adenocarcinoma; Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY;

EID: 0030863982     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64243-5     Document Type: Article

References (31)

1. Wingo, P. A., Tong, T. and Bolden, S.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. JAMA, 274: 626, 1995.
3. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W., Chisolm, G. D., Moskovitz, B., Livne, P. M. and Warner, J.: Results of conservative management of clinically localized prostate cancer. New Engl. J. Med., 330: 242, 1994.
4. Johansson, J. E., Adami, H. O., Andersson, S. O., Bergstrom, R., Holmberg, L. and Krusemo, U. B.: High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA, 267: 2191, 1992.
5. Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J. and Wennberg, J. E.: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA, 269: 2650, 1993.
6. Aus, G., Hugosson, J. and Norlén, L.: Risk of dying of prostate cancer in different stages, grades and age at diagnosis. J. Urol., part 2, 151: 278A, abstract 203, 1994.
7. Gleason, D. F. and Mellinger, G. T.: The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostate carcinoma by combined histological grading and clinical staging. J. Urol., 111: 58, 1974.
8. Gleason, D. F.: Histologic grading of prostate cancer: a perspective. Hum. Path., 23: 273, 1992.
9. Thomas, R., Lewis, R. W., Sarma, D. P., Coker, G. B., Rao, M. K. and Roberts, J. A.: Aid to accurate clinical staging-histopathologic grading in prostatic cancer. J. Urol., 128: 726, 1982.
10. Kramer, S. A., Spahr, J., Brendler, C. B., Glenn, J. F. and Paulson, D. F.: Experience with Gleason's histopathologic grading in prostate cancer. J. Urol., 124: 223, 1980.
11. Kozlowski, J. M. and Grayhack, J. T.: Carcinoma of the prostate. In: Adult and Pediatric Urology, 2nd ed. Edited by J. Y. Gillenwater, J. T. Grayhack, S. S. Howards and J. W. Duckett. St. Louis: Mosby Year Book, chapt. 34, pp. 1277-1394, 1991.
12. Schroder, F. H., Hermanek, P., Denis, L., Fair, W. R., Gospodarowicz, M. K. and Pavone-Macaluso, M.: The TNM classification of prostate cancer. Prostate, suppl., 4: 129, 1992.
13. Epstein, J. I.: The evaluation of radical prostatectomy specimens. Therapeutic and prognostic implications. Path. Ann., 26: 159, 1991.
14. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
15. Cox, D. R.: Regression models and life-tables. J. Roy. Stat. Soc., 34: 187, 1972.
16. SAS/STAT User's Guide, Version 6.07. Cary, North Carolina: SAS Institute, Inc., 1992.
17. Jewett, H. J., Bridge, R. W., Gray, G. F., Jr. and Shelley, W. M.: The palpable nodule of prostatic cancer. Results 15 years after radical incision. JAMA, 203: 403, 1968.
18. Oefelein, M. G., Grayhack, J. T. and McVary, K. T.: Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer, 76: 2535, 1995.
19. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
20. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
21. Zincke, H., Bergstalh, E. J., Blute, M. L., Myers, R. P., Barrett, D. M., Lieber, M. M., Martin, S. K. and Oesterling, J. E.: Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J. Clin. Oncol., 12: 2254, 1994.
22. Partin, A. W., Lee, B. R., Carmichael, M., Walsh, P. C. and Epstein, J. I.: Radical prostatectomy for high grade disease: a reevaluation 1994. J. Urol., 151: 1583, 1994.
23. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. and Scardino, P. T.: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol., part 2, 152: 1843, 1994.
24. Pearle, M. S., Oyasu, R., Hidvegi, D., Sutkowski, D., Rademaker, A., Cajulis, R., Grayhack, J. T. and McVary, K. T.: Touch preparation cytological evaluation of radical prostatectomy specimens. J. Urol., 152: 124, 1994.
25. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.
26. Oefelein, M. G., Kaul, K, Ignatoff, J. M. and Herz, B.: Hematogenous dissemination of prostate epithelial cells during surgery. Lancet, 347: 324, 1996.
27. Hofer, D. R., Garnett, J. and Grayhack, J. T.: The role of perineal needle biopsy on local recurrence of prostate cancer. J. Urol., part 2, 141: 282A, abstract 450, 1989.
28. Wood, D. P., Jr., Weinstein, M., Humpries, S. and Rangnekar, V. M.: Prognostic significance of circulating prostate cells. J. Urol., part 2, 155: 418A, abstract 429, 1996.
29. Edelstein, R. A., Zietman, A. L., de las Morenas, A., Krane, R. J., Babayan, R. K., Dallow, K. C., Traish, A. and Moreland, R. B.: Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47: 370, 1996.
30. Olsson, C. A., de Vries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K., Cao, Y., Buttyan, R. E. and Katz, A. E.: Preoper-ative reverse transcriptase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155: 1557, 1996.
31. Oefelein, M. G., Smith, N., Carter, M., Dalton, D. and Schaeffer, A.: The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J. Urol., 154: 2128, 1995.